Friday, February 06, 2026 | 07:38 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Novartis India Ltd / News

Novartis India Ltd News

Novartis nears deal to acquire Avidity Biosciences for over $70 per share

Avidity rose 1.2% to close at $49.15 in New York trading Friday, giving the company a market value of about $6.8 billion

Novartis nears deal to acquire Avidity Biosciences for over $70 per share
Updated On : 26 Oct 2025 | 9:27 PM IST

Novartis' Vymada patent revoked, generics set to slash prices by 70%

Novartis lost its Vymada patent in India, enabling generic drugmakers to launch versions that could slash prices by up to 70 per cent and improve access for cardiac patients

Novartis' Vymada patent revoked, generics set to slash prices by 70%
Updated On : 16 Sep 2025 | 7:49 PM IST